journal article·2024-02Open access

Laponite for biomedical applications: An ophthalmological perspective

Maria J. Rodrigo, Maria J. Cardiel, Jose M. Fraile, Jose A. Mayoral, Luis E. Pablo, Elena Garcia-Martin

Abstract

Clay minerals have been applied in biomedicine for thousands of years. Laponite is a nanostructured synthetic clay with the capacity to retain and progressively release drugs. In recent years there has been a resurgence of interest in Laponite application in various biomedical areas. This is the first paper to review the potential biomedical applications of Laponite in ophthalmology. The introduction briefly covers the physical, chemical, rheological, and biocompatibility features of different routes of administration. After that, emphasis is placed on 1) drug delivery for antibiotics, anti-inflammatories, growth factors, other proteins, and cancer treatment; 2) bleeding prevention or treatment; and 3) tissue engineering through regenerative medicine using scaffolds in intraocular and extraocular tissue. Although most scientific research is not performed on the eye, both the findings and the new treatments resulting from that research are potentially applicable in ophthalmology since many of the drugs used are the same, the tissue evaluated in vitro or in vivo is also present in the eye, and the pathologies treated also occur in the eye. Finally, future prospects for this emerging field are discussed.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Pancreatic and Hepatic Oncology Research · Cellular Mechanics and Interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Nanoclays in medicine: a new frontier of an ancient medical practice10.1039/D2MA00528J ↗
2. Ebers Papyrus | The National Archives, (n.d.). https://discovery.nationalarchives.gov.uk/details/r/58a9bba9-1312-487a-9a6f-829ccd091d21 (accessed August 14, 2023).
3. E. Strouhal, B. Vachala, H. Vymazalová, S.M. Miller, The medicine of the ancient Egyptians, The Medicine of the Ancient Egyptians. American Univ. in Cairo Press. Pag 1-240 (n.d.). https://books.google.com/books/about/Medicine_of_the_Ancient_Egyptians.html?hl=es&id=im9IzQEACAAJ (accessed August 15, 2023).
4. The structure of the micas and related minerals10.1073/pnas.16.2.123 ↗
5. Layered double hydroxide-based nanomaterials for biomedical applications10.1039/D2CS00236A ↗
6. Functionalized hexagonal boron nitride nanomaterials: emerging properties and applications10.1039/C5CS00869G ↗
7. Functionalized MoS2-nanoparticles for transdermal drug delivery of atenolol10.1080/10717544.2020.1778815 ↗
8. Dr Barbara S. Neumann: clay scientist and industrial pioneer; creator of Laponite®10.1180/clm.2020.35 ↗
9. Behaviour of a synthetic clay in pigment dispersions10.1007/BF01973660 ↗
10. Neumann · Synthetic hectorite-type clay minerals · 1967 · 401 · 107
11. Taylor: Nature of synthetic swelling clays and their... - Google Académico, (n.d.). Page 777-780. https://scholar.google.com/scholar_lookup?title=Nature+of+synthetic+swelling+clays+and+their+use+in+emulsion+paint&author=Taylor+J.&author=Neumann+B.S.&publication+year=1968&journal=Journal+of+the+Oil+and+Colour+Chemists%E2%80%99+Association&volume=51&pages=232-253 (accessed December 9, 2023)..
12. Laponite-based nanomaterials for biomedical applications: a review10.2174/1381612825666190402165845 ↗
13. A key nanoplatform for biomedical applications?10.1016/j.nano.2017.04.016 ↗
14. Biomedical applications of laponite®-based nanomaterials and formulations10.1007/978-3-030-80924-9_15 ↗
15. Laponite-based nanomaterials for drug delivery10.1002/adhm.202102054 ↗
16. Injectable and cell-laden hydrogel in the contained bone defect animal model: a systematic review
17. 2D nanoclay for biomedical applications: regenerative medicine, therapeutic delivery, and additive manufacturing10.1002/adma.201900332 ↗
18. Overview — clay mineral applications10.1016/0169-1317(91)90014-Z ↗
19. Clay Mineralogy: the clay mineral composition of soils and clays is providing an understanding of their properties10.1126/science.135.3507.890 ↗
20. Clays, nanoclays, and montmorillonite minerals10.1007/s11661-008-9603-5 ↗
21. Development of biomedical polymer-silicate nanocomposites: a materials science perspective10.3390/ma3052986 ↗
22. Mechanical, swelling, and structural properties of mechanically tough clay-sodium polyacrylate blend hydrogels10.3390/gels3010010 ↗
23. Clay-based nanocomposite hydrogels for biomedical applications: a review10.3390/nano12193308 ↗
24. Polysaccharide-silicate composite hydrogels: review on synthesis and drug delivery credentials
25. Adsorption of fluorophores and N-isopropylacrylamide on laponite10.1016/j.clay.2012.01.021 ↗
26. Luminescent hybrid materials based on laponite clay10.1002/chem.201402794 ↗
27. Observation of empty liquids and equilibrium gels in a colloidal clay10.1038/nmat2921 ↗
28. Monitoring new long-lasting intravitreal formulation for glaucoma with vitreous images using optical coherence tomography10.3390/pharmaceutics13020217 ↗
29. Green biosynthesis of superparamagnetic magnetite Fe3O4 nanoparticles and biomedical applications in targeted anticancer drug delivery system: a review10.1016/j.arabjc.2018.04.013 ↗
30. Laponite® and Laponite®-PEO hydrogels with enhanced elasticity in phosphate-buffered saline10.1002/pat.3514 ↗
31. Cell-loaded injectable gelatin/alginate/LAPONITE® nanocomposite hydrogel promotes bone healing in a critical-size rat calvarial defect model10.1039/D0RA03040F ↗
32. Thixotropy—a review10.1016/S0377-0257(97)00004-9 ↗
33. Smart shear-thinning hydrogels as injectable drug delivery systems10.3390/polym10121317 ↗
34. Highly tough, biocompatible, and magneto-responsive Fe3O4/laponite/PDMAAm nanocomposite hydrogels
35. Design of biocompatible chitosan/polyaniline/laponite hydrogel with photothermal conversion capability10.3390/biom12081089 ↗
36. One-step fabrication of biocompatible multifaceted nanocomposite gels and nanolayers10.1021/acs.biomac.6b01483 ↗
37. Structural and morphological properties of in-situ biosynthesis of biocompatible bacterial cellulose/Laponite nanocomposites10.1016/j.clay.2023.106851 ↗
38. Physically crosslinked nanocomposites from silicate-crosslinked PEO: mechanical properties and osteogenic differentiation of human mesenchymal stem cells10.1002/mabi.201100508 ↗
39. Preparation of laponite bioceramics for potential bone tissue engineering applications
40. Safety study of intravitreal and suprachoroidal Laponite clay in rabbit eyes10.1007/s00417-017-3893-5 ↗
41. Bioactive silicate nanoplatelets for osteogenic differentiation of human mesenchymal stem cells10.1002/adma.201300584 ↗
42. Inorganic clay nanocomposite system for improved cholinesterase inhibition and brain pharmacokinetics of donepezil10.1080/03639045.2019.1698594 ↗
43. Toxicological evaluation of clay minerals and derived nanocomposites: a review10.1016/j.envres.2014.12.024 ↗
44. Effect of fluoride doping in laponite nanoplatelets on osteogenic differentiation of human dental follicle stem cells (hDFSCs)10.1038/s41598-018-37327-7 ↗
45. Dissociation of nanosilicates induces downstream endochondral differentiation gene expression program10.1126/sciadv.abl9404 ↗
46. The nature of laponite and its aqueous dispersions10.1016/0021-9797(92)90254-J ↗
47. Laponite as carrier for controlled in vitro delivery of dexamethasone in vitreous humor models10.1016/j.ejpb.2016.08.015 ↗
48. Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulation10.1088/1748-605X/aba445 ↗
49. Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model10.1039/D0BM01013H ↗
50. Suprachoroidal delivery of small molecules, nanoparticles, gene and cell therapies for ocular diseases10.3390/pharmaceutics13020288 ↗
51. Recent advances in ophthalmic drug delivery10.3390/pharmaceutics14102075 ↗
52. Patent review on nanotechnology in ocular drug delivery10.2174/18779123112029990004 ↗
53. Natural and synthetic clay minerals in the pharmaceutical and biomedical fields10.3390/pharmaceutics15051368 ↗
54. Growth factor delivery: defining the next generation platforms for tissue engineering10.1016/j.jconrel.2019.05.028 ↗
55. Biomedical applications of cationic clay minerals10.1039/C4RA16945J ↗
56. A review on tough and sticky hydrogels10.1007/s00396-013-3021-y ↗
57. Clay nanoparticles as pharmaceutical carriers in drug delivery systems10.1080/17425247.2021.1862792 ↗
58. Current challenges in clay minerals for drug delivery10.1016/j.clay.2010.01.007 ↗
59. Controlled drug delivery: historical perspective for the next generation10.1016/j.jconrel.2015.10.005 ↗
60. Injectable nanocomposite cryogels for versatile protein drug delivery10.1016/j.actbio.2017.11.024 ↗
61. 2D layered nanomaterials for therapeutics delivery
62. Poly(N-vinylpyrrolidone)–Laponite XLG nanocomposite hydrogels: characterization, properties and comparison with divinyl monomer-crosslinked hydrogels10.3390/polym14194216 ↗
63. K213385-Janice Hogan, (n.d.). https://www.fda.gov/medical- (accessed August 15, 2023)..
64. pH sensitive dexamethasone encapsulated laponite nanoplatelets: release mechanism and cytotoxicity10.1016/j.ijpharm.2017.01.001 ↗
65. Chemical stability phase diagram of aqueous Laponite dispersions10.1016/j.clay.2015.10.021 ↗
66. Surface patch binding induced interaction of anisotropic nanoclays with globular plasma proteins10.1039/C6RA11669H ↗
67. Laponite clay as a carrier for in situ delivery of tetracycline10.1039/c3ra43217c ↗
68. Encapsulation of amoxicillin within laponite-doped poly(lactic-co-glycolic acid) nanofibers: preparation, characterization, and antibacterial activity10.1021/am302130b ↗
69. Fabrication of laponite-reinforced dextran-based hydrogels for NIR-responsive controlled drug release10.1021/acsbiomaterials.1c01389 ↗
70. Antibiotic eluting clay mineral (Laponite®) for wound healing application: an in vitro study10.1007/s10856-014-5272-7 ↗
71. Aminofunctionalized LAPONITE® as a versatile hybrid material for chlorhexidine digluconate incorporation: cytotoxicity and antimicrobial activities10.1016/j.clay.2020.105733 ↗
72. Nanoclay-polyamine composite hydrogel for topical delivery of nitric oxide gas via innate gelation characteristics of laponite10.1021/acs.biomac.0c00086 ↗
73. Copper-doped nano laponite coating on poly(butylene succinate) scaffold with antibacterial properties and cytocompatibility for biomedical application10.1155/2018/5470814 ↗
74. Biofouling mitigation effect of thin film nanocomposite membranes immobilized with laponite mediated metal ions10.1016/j.desal.2019.114162 ↗
75. Interaction of laponite with membrane components-consequences for bacterial aggregation and infection confinement10.1021/acsami.9b03527 ↗
76. Layered silicate-alginate composite particles for the pH-mediated release of theophylline10.3390/ph13080182 ↗
77. Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders10.1039/D0TB02957B ↗
78. Itraconazole–Laponite: kinetics and mechanism of drug release10.1016/j.clay.2007.09.002 ↗
79. Cellulose/pectin-based materials incorporating Laponite-indole derivative hybrid for oral administration and controlled delivery of the neuroprotective drug10.1016/j.ijbiomac.2023.123765 ↗
80. The use of a laponite dispersion to increase the hydrophilicity of cobalt-ferrite magnetic nanoparticles10.1016/j.clay.2020.105663 ↗
81. Spectroscopic study of carbaryl sorption on smectite from aqueous suspension10.1021/es048108s ↗
82. A study the interaction forces between the bovine serum albumin protein and montmorillonite surface10.1016/j.colsurfa.2012.08.066 ↗
83. Controlled release of epigenetically-enhanced extracellular vesicles from a GelMA/nanoclay composite hydrogel to promote bone repair10.3390/ijms23020832 ↗
84. miR-23a-3p-abundant small extracellular vesicles released from Gelma/nanoclay hydrogel for cartilage regeneration10.1080/20013078.2020.1778883 ↗
85. Tough composite hydrogels with high loading and local release of biological drugs10.1002/adhm.201701393 ↗
86. Injectable nanoclay gels for angiogenesis10.1016/j.actbio.2019.09.023 ↗
87. An injectable heparin-Laponite hydrogel bridge FGF4 for spinal cord injury by stabilizing microtubule and improving mitochondrial function10.7150/thno.37601 ↗
88. Bisphosphonate nanoclay edge-site interactions facilitate hydrogel self-assembly and sustained growth factor localization
89. Sustained and prolonged delivery of protein therapeutics from two-dimensional nanosilicates10.1021/acsami.8b17733 ↗
90. Stem cell secretome-rich nanoclay hydrogel: a dual action therapy for cardiovascular regeneration10.1039/C5NR07806G ↗
91. Clay gels for the delivery of regenerative microenvironments10.1002/adma.201100968 ↗
92. Bone induction at physiological doses of BMP through localization by clay nanoparticle gels10.1016/j.biomaterials.2016.05.010 ↗
93. Emerging role of nanoclays in cancer research, diagnosis, and therapy10.1016/j.ccr.2021.213956 ↗
94. Physically-triggered nanosystems based on two-dimensional materials for cancer theranostics10.1016/j.addr.2018.08.010 ↗
95. Nano drug delivery system for tumor immunotherapy: next-generation therapeutics
96. Delicate hybrid laponite–cyclic poly(ethylene glycol) nanoparticles as a potential drug delivery system10.3390/pharmaceutics15071998 ↗
97. Soft nanohydrogels based on laponite nanodiscs: a versatile drug delivery platform for theranostics and drug cocktails10.1021/acsami.8b06149 ↗
98. Laponite nanodisks as an efficient platform for Doxorubicin delivery to cancer cells10.1021/la4001363 ↗
99. Fine tuning of the pH-sensitivity of laponite-doxorubicin nanohybrids by polyelectrolyte multilayer coating10.1016/j.msec.2015.11.051 ↗
100. pH-sensitive Laponite(®)/doxorubicin/alginate nanohybrids with improved anticancer efficacy10.1016/j.actbio.2013.09.013 ↗